CC

Active Director Director DIN 08548177
DIN 08548177 First appointment Aug 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Chao Chen

Data last updated:

Chao Chen is a Director at Genrui Biotech India Private Limited (since 2019). The company operates in Healthcare. Genrui Biotech India Private Limited reported revenue of ₹6.83 Cr (FY 2025).

DIN 08548177
Primary Designation Director
Industry Healthcare
First Appointment 28 Aug 2019
Oldest Company Age 7 yrs
Largest company Genrui Biotech India Private Limited · ₹6.83 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genrui Biotech India Private Limited U51909MH2019FTC329844
Director28 Aug 20192019₹6.83 Cr (FY 2025)Active

Board colleagues of Chao Chen

NameDINCompanyDesignation
Ahtsham Ahmad08435892Genrui Biotech India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Genrui Biotech India Private Limited
Premium access

Shareholding and investment profile for Chao Chen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chao Chen

Chao Chen currently holds 1 directorship: Genrui Biotech India Private Limited (Director, since 28 Aug 2019, revenue ₹6.83 Cr (FY 2025)).

Chao Chen was first appointed on 28 Aug 2019 as Director at Genrui Biotech India Private Limited.

The current boards of Chao Chen's companies include Ahtsham Ahmad (Genrui Biotech India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available